Heart Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have had their aortic heart valve replaced using a catheter-based procedure (called TAVR) where the catheter was inserted through an artery in the groin (transfemoral approach).
Who may not be able to join:
- People whose TAVR procedure used an access point other than the groin artery (for example, through the chest or arm).
- People whose procedure involved placing a new valve inside an already-existing replacement valve.
- People who have previously had a biological (tissue-based) replacement heart valve implanted at any time in the past.
- People who have a pacemaker, an implantable heart shock device (ICD), or a cardiac resynchronization therapy (CRT) device.
- People who have been diagnosed with liver cirrhosis (severe scarring of the liver).
- People who have a condition affecting the esophagus (the tube connecting the throat to the stomach), including swollen veins in the esophagus (esophageal varices).
- People who have a low platelet count or problems with blood clotting.
- People who have a medical or psychiatric condition — such as dementia, alcoholism, or substance misuse — that may affect their ability to give informed consent or participate fully in the study, including follow-up visits.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Malte Kelm, Prof., Division of Cardiology, Pulmonary Disease and Vascular Medicine
Phone: 0211 81 18800
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Presence of a commissural alignment; Presence of symmetrical position; Transvalvular gradients; Effective orifice area (EOA); Doppler velocity index; Paravalvular leakage; Turbulent flow; Pressure recovery; Energy loss coefficient; global coronary flow reserve; Peak velocity; Wall sheer stress; Flow displacement; aortic area; volumen; LV-Function; RV-Function; Strain
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.